Trade name: Hiprabovis 4
Active substance: V IBR tulpina LA, VPi3 tulpina SF4, VBVD tulpina NADL, VSRB tulpina LYMP 56
Therapeutic group: Organic products
Pharmaceutical form: liofilizat şi solvent pentru suspensie injectabilă
Presentation: cutie x 5 doze, 30 doze (componentă liofilizată + componentă lichidă)
Target species: cattle
Therapeutic action: Bovine Imunoprofilaxia infectiilor cu IBRv, PI3, BVD, BRSV.
Waiting period: 0 zile.
Release mode: Cu prescripţie
Authorization number: 110305
Authorization status: Valida
Date of issue of the authorization: 14-11-2011
Authorization valid until: nelimitata
Manufacturer / Serial Release Company: LABORATORIOS HIPRA S.A., Spania
Licensee: LABORATORIOS HIPRA S.A., Spania